BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2526489)

  • 21. Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin.
    Undas A; Placzkiewicz-Jankowska E; Zieliński L; Tracz W
    Thromb Haemost; 2007 Jun; 97(6):1056-8. PubMed ID: 17549314
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of omega-3 fatty acids on the prostaglandin system in healthy volunteers.
    Gazsó A; Kaliman J; Horrobin D; Sinzinger H
    Prog Clin Biol Res; 1989; 301():517-21. PubMed ID: 2508117
    [No Abstract]   [Full Text] [Related]  

  • 23. [The inhibition of thrombocyte aggregation in vitro and in vivo].
    Breddin K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):460-9. PubMed ID: 4193162
    [No Abstract]   [Full Text] [Related]  

  • 24. Aspirin, platelets, and thrombosis: theory and practice.
    Roth GJ; Calverley DC
    Blood; 1994 Feb; 83(4):885-98. PubMed ID: 8111062
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet prostanoids in interaction of platelets with collagen substrates. II. Effects of exogenous arachidonic acid, stable PG endoperoxides analogue, and aspirin.
    Mazurov AV; Leytin VL; Repin VS; Taube C; Förster W
    Biomed Biochim Acta; 1984; 43(8-9):S373-6. PubMed ID: 6440553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of platelets in arterial hypotension induced by arachidonic acid and in carrageenan induced edema in the rat].
    Damas J; Volon G
    C R Seances Soc Biol Fil; 1979; 173(4):843-8. PubMed ID: 160830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Platelet suppressive drugs (author's transl)].
    Shio H; Kameyama M
    No Shinkei Geka; 1981 Feb; 9(2):113-22. PubMed ID: 6264335
    [No Abstract]   [Full Text] [Related]  

  • 29. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent to collagen.
    Kinlough-Rathbone RL; Cazenave JP; Packham MA; Mustard JF
    Lab Invest; 1980 Jan; 42(1):28-34. PubMed ID: 7351829
    [No Abstract]   [Full Text] [Related]  

  • 32. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study.
    Watala C; Ulicna O; Golanski J; Nocun M; Waczulíková I; Markuszewski L; Drzewoski J
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):113-24. PubMed ID: 16479193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis.
    Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF
    Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin dosage and antithrombotic effect.
    Clagett GP; Russo M; Hufnagel H; Collins GJ; Rich NM
    Surg Forum; 1979; 30():199-201. PubMed ID: 538593
    [No Abstract]   [Full Text] [Related]  

  • 37. Possible significance of small numbers of functional platelets in a population of aspirin-treated platelets in vitro and in vivo.
    Cerskus AL; Ali M; Davies BJ; McDonald JW
    Thromb Res; 1980 May 1-15; 18(3-4):389-97. PubMed ID: 7414538
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: Platelet-function tests: predictive value.
    Pevine PL
    N Engl J Med; 1975 Jun; 292(25):1346-7. PubMed ID: 1168852
    [No Abstract]   [Full Text] [Related]  

  • 39. On the mechanism of platelet activation during hemostasis and thrombosis and on the effects of platelet inhibiting drugs.
    Breddin K; Bender N; Kirchmaier CM
    Adv Exp Med Biol; 1984; 164():145-54. PubMed ID: 6421101
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute hypotension due to carrageenan, arachidonic acid and slow reacting substance C in the rabbit: role of platelets and nature of pharmacological antagonism.
    Vargaftig BB; Lefort J
    Eur J Pharmacol; 1977 May; 43(2):125-41. PubMed ID: 17539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.